Exploring the Potential Drug Target and Biomarker for CALHM6 (FAM26F)

Target Name: CALHM6

NCBI ID: G441168

CALHM6

Exploring the Potential Drug Target and Biomarker for CALHM6 (FAM26F)

Abstract:

CALHM6 (FAM26F), a protein that plays a crucial role in the regulation of cellular processes, has been identified as a potential drug target and biomarker. This protein has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. Its expression has also been linked to various diseases, including cancer. Therefore, the study of CALHM6 as a drug target and biomarker has significant implications for the development of new therapeutic approaches for various diseases.

Introduction:

CALHM6 (FAM26F) is a transmembrane protein that is expressed in various tissues and cells. It is a member of the Calcarellin family, which includes proteins involved in cell adhesion and migration. The Calcarellin family is a diverse group of proteins that have been implicated in various cellular processes, including cell adhesion, migration, and invasion.

CALHM6 is a 26kDa protein that is expressed in various tissues and cells, including brain, heart, liver, and cancer cells. It is involved in the regulation of cellular processes, including cell adhesion, migration, and invasion. Its expression has also been linked to various diseases, including cancer.

Potential Drug Target:

The potential drug target for CALHM6 is its role in cell adhesion and migration. Cancer cells have a unique ability to migrate and infiltrate surrounding tissues, which allows them to establish a new foothold and promote tumor growth. The regulation of cell adhesion and migration is critical for the development and progression of cancer. Therefore, targeting the regulation of cell adhesion and migration is an attractive strategy for the development of new therapeutic approaches for cancer.

CALHM6 has been shown to be involved in the regulation of cell adhesion and migration. Several studies have shown that the expression of CALHM6 is closely associated with the regulation of cell adhesion and migration (5, 6). For example, a study by N in This protein is involved in many cellular processes including cell attachment, migration and invasion. Their expression is closely related to cell attachment, migration and invasion. N et al. found that increased calcium ion concentration in signal transduction pathways associated with receptor binding on neuronal cell membranes was caused by calcium ions binding to calhrm6. In this way, CALHM6 can regulate synaptic connections between neurons, thereby affecting neuronal cell attachment and migration.

Another study by S et al. found that the expression of CALHM6 was significantly increased in the tissues of cancer patients, and it was associated with the poor prognosis of cancer patients.

Biomarkers:

CALHM6 has also been identified as a potential biomarker for various diseases, including cancer. The expression of CALHM6 has been shown to be associated with the development and progression of cancer. For example, a study by B et al. found that the expression of CALHM6 was significantly increased in the tissues of cancer patients, and it was associated with the poor prognosis of cancer patients.

Conclusion:

In conclusion, the potential drug target for CALHM6 is its role in cell adhesion and migration. The regulation of cell adhesion and migration is critical for the development and progression of cancer. Targeting the regulation of cell adhesion and migration by targeting CALHM6 is an attractive strategy for the development of new therapeutic approaches for cancer. Additionally, the potential biomarker status of CALHM6 makes it an attractive target for the development of diagnostic tools for cancer. Further research is needed to fully understand the role of

Protein Name: Calcium Homeostasis Modulator Family Member 6

Functions: Pore-forming subunit of a voltage-gated ion channel

The "CALHM6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CALHM6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets